Fairvalue-Calculator Fairvalue-Calculator
EN DE

ESG Inc (ESGH) Fair Value & Analysis

Consumer Defensive · US · Market cap $27.7M

Price$1.79
Fair Value$1.70
Upside-5.0%
Quality80/100
Evidence: Medium Range $1.27 – $2.12

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

ESG Inc (ESGH) currently trades at $1.79, while our model-based Fair Value estimate is $1.70 — implying the stock looks roughly 5.0% overvalued today. We read business quality at 80/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

ESG Inc., a cold plasma application company, develops and operates in plant-based ingredients, and food production and distribution businesses. It engages in research and development, composting, cultivation, processing, packaging, and distribution of white button mushrooms. The company also exports its products. ESG Inc. is headquartered in Kennett Square, Pennsylvania.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is ESG Inc (ESGH) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $1.70 versus a price of $1.79 — about −5% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ESGH?
Our 21-model fair value for ESG Inc is $1.70 (as of Jun 24, 2026), built from audited fundamentals. The current price is $1.79.
What is the quality score of ESGH?
ESG Inc has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.